Follow
F Xavier Romero-Durán
F Xavier Romero-Durán
MD PhD
Verified email at rai.usc.es
Title
Cited by
Cited by
Year
Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives
FJ Romero-Duran, N Alonso, M Yanez, O Caamano, X García-Mera, ...
Neuropharmacology 103, 270-278, 2016
682016
TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1, 3-rasagiline derivatives potentially useful in neurodegenerative …
F Luan, MNDS Cordeiro, N Alonso, X García-Mera, O Caamaño, ...
Bioorganic & medicinal chemistry 21 (7), 1870-1879, 2013
672013
Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates
N Alonso, O Caamano, FJ Romero-Duran, F Luan, MN DS Cordeiro, ...
ACS chemical neuroscience 4 (10), 1393-1403, 2013
612013
Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1, 2-rasagiline carbamates
FJ Romero Durán, N Alonso, O Caamaño, X García-Mera, M Yañez, ...
International journal of molecular sciences 15 (9), 17035-17064, 2014
382014
Response to intravenous lidocaine in a patient with SUNCT syndrome
AM Arroyo, XR Durán, MG Beldarrain, A Pinedo, JC García-Moncó
Cephalalgia 30 (1), 110-112, 2010
352010
Improving neuropharmacology using big data, machine learning and computational algorithms
K Shameer, A Nayarisseri, FXR Duran, H González-Díaz
Current Neuropharmacology 15 (8), 1058, 2017
292017
Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of US counties
DM Herrera-Ibatá, A Pazos, RA Orbegozo-Medina, FJ Romero-Durán, ...
Biosystems 132, 20-34, 2015
242015
Multi-target mining of Alzheimer disease proteome with Hansch’s QSBR-perturbation theory and experimental-theoretic study of new thiophene isosters of rasagiline
P Abeijon, X Garcia-Mera, O Caamano, M Yanez, E Lopez-Castro, ...
Current Drug Targets 18 (5), 511-521, 2017
202017
Experimental-theoretic approach to drug-lymphocyte interactome networks with flow cytometry and spectral moments perturbation theory
P Abeijón, X García-Mera, O Caamaño, M Yañez, E López-Castro, ...
Current Pharmaceutical Design 22 (33), 5114-5119, 2016
32016
Glaucoma agudo secundario a topiramato: a propósito de 2 casos
X Romero Duran, J Ruiz Ojeda, JL Sánchez Menoyo, C Aguirre Gómez
Medicina Clínica 140 (5), 235-235, 2013
12013
USEDAT-NEURODAT’21 IBRO-PERC Training Program
R Isasi, AL Svalastog, Y Perez-Riverol, S Knafo, A Duardo-Sanchez, ...
MDPI, 2022
2022
NEURODAT'21 IBRO-PERC Lecture on Neuromorphic Engineering
FJ Romero-Duran
MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and …, 2021
2021
NEURODAT'21 IBRO-PERC Lecture on Neuroinformatics
F Romero-Duran
MDPI, 2021
2021
NEURODAT'21 IBRO-PERC Lecture on Models, Simulations, and Self-Awareness
F Romero-Duran
MDPI, 2021
2021
NEURODAT'21 IBRO-PERC Lecture on Databases in Neurosciences
F Romero-Duran
MDPI, 2021
2021
Modelos neuroinformáticos para a descoberta de fármacos neuroprotectores
FX Romero Durán
2016
Multi-target Prediction of Neuroprotective Drugs, Synthesis, Assay, and Theoretical Study of Rasagiline Carbamates
MYXGM Francisco J Romero Durán , Nerea Alonso , Olga Caamaño
Proceedings of the MOL2NET, 5–15 December 2015; 2015 , b020 1, 2015
2015
Examen neurológico
Examen neurológico, 440 páginas, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–18